B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Nuclear Envelope Breakdown

REACTOME PATHWAY
Reactome: R-HSA-29807668 genes30 compounds

The Nuclear Envelope Breakdown pathway (Reactome ID: R-HSA-2980766) involves 8 genes and is affected by 30 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CCNB1CCNB2CDK1LMNANEK6NEK7NEK9PLK1

Compounds Affecting Nuclear Envelope Breakdown

#CompoundTargets HitStudies
1kenpaullone8
2alsterpaullone12
3indirubin300
4Apigenin 5,7,4'-trihydroxy-flavone,300
5chrysin300
6fisetin78
7Luteolin 5,7,3',4'-tetrahydroxy-flavone,150
8Quercetin300
9Crizotinib298
10Clofibrate299
11Fenofibrate297
12Sertraline1,000
13Cinnarizine299
14Clotrimazole296
15Rotenone300
16Sorafenib300
17sp600125117
18ly29400211
19Wortmannin300
20myricetin-3-O-galactopyranoside [Supplementary Concept]300
21Oleic Acid112
22Simvastatin1,000
23cefaclor299
24Disulfiram297
25Hexachlorophene300
26Lithocholic Acid300
27Nisoldipine297
28Oxyphenbutazone300
29Oxytetracycline300
30Histamine300

About the Nuclear Envelope Breakdown Pathway

The Nuclear Envelope Breakdown pathway is catalogued in Reactome (ID: R-HSA-2980766) and involves 8 genes. In the BiohacksAI corpus, 30 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CCNB1, CCNB2, CDK1, LMNA, NEK6.